Shares of Healthways Inc. (NASDAQ:HWAY) were down 2.7% during trading on Wednesday . The company traded as low as $24.76 and last traded at $24.88, with a volume of 213,843 shares traded. The stock had previously closed at $25.58.

Several equities analysts have recently issued reports on HWAY shares. Zacks Investment Research lowered shares of Healthways from a “buy” rating to a “hold” rating in a report on Tuesday. Barclays PLC raised shares of Healthways from an “underweight” rating to an “equal weight” rating and boosted their price target for the company from $12.00 to $27.00 in a report on Monday, August 22nd. Jefferies Group set a $26.00 price target on shares of Healthways and gave the company a “hold” rating in a report on Thursday, August 18th. Oppenheimer Holdings Inc. raised shares of Healthways to an “outperform” rating and set a $27.00 price target for the company in a report on Sunday, August 14th. Finally, FBR & Co boosted their price target on shares of Healthways from $16.00 to $21.00 and gave the company an “outperform” rating in a report on Wednesday, August 10th. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $24.21.

The company’s market cap is $941.59 million. The company’s 50 day moving average is $23.38 and its 200-day moving average is $14.64.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/healthways-inc-hway-trading-down-2-7.html

Healthways (NASDAQ:HWAY) last posted its quarterly earnings results on Tuesday, August 9th. The company reported $0.54 EPS for the quarter, topping analysts’ consensus estimates of $0.01 by $0.53. The business earned $125 million during the quarter, compared to analysts’ expectations of $186.88 million. Healthways had a negative net margin of 31.32% and a positive return on equity of 8.83%. The business’s quarterly revenue was up 10.2% on a year-over-year basis. During the same period last year, the company posted $0.11 earnings per share. Equities analysts predict that Healthways Inc. will post $2.11 earnings per share for the current fiscal year.

In other Healthways news, Director Mary Jane England sold 3,816 shares of the firm’s stock in a transaction on Friday, August 26th. The shares were sold at an average price of $24.78, for a total value of $94,560.48. Following the completion of the sale, the director now directly owns 39,068 shares in the company, valued at $968,105.04. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 14.01% of the stock is currently owned by company insiders.

A number of large investors have recently bought and sold shares of the company. Prudential Financial Inc. boosted its position in shares of Healthways by 3.6% in the first quarter. Prudential Financial Inc. now owns 73,984 shares of the company’s stock worth $746,000 after buying an additional 2,600 shares in the last quarter. BlackRock Fund Advisors boosted its position in shares of Healthways by 1.7% in the first quarter. BlackRock Fund Advisors now owns 2,251,011 shares of the company’s stock worth $22,713,000 after buying an additional 37,357 shares in the last quarter. Royce & Associates LP boosted its position in shares of Healthways by 13.4% in the first quarter. Royce & Associates LP now owns 903,204 shares of the company’s stock worth $9,113,000 after buying an additional 106,500 shares in the last quarter. State Street Corp boosted its position in shares of Healthways by 5.2% in the first quarter. State Street Corp now owns 817,665 shares of the company’s stock worth $8,246,000 after buying an additional 40,638 shares in the last quarter. Finally, Geode Capital Management LLC boosted its position in shares of Healthways by 2.2% in the first quarter. Geode Capital Management LLC now owns 237,795 shares of the company’s stock worth $2,399,000 after buying an additional 5,130 shares in the last quarter. Institutional investors and hedge funds own 92.52% of the company’s stock.

Healthways Company Profile

Healthways, Inc (Healthways) provides network delivered solutions and population health management services that are designed to help people manage their wellbeing, thereby managing their health and productivity, and their health-related costs. The Company operates in the domestic and international segments, which are collectively known as the well-being improvement services segment.

5 Day Chart for NASDAQ:HWAY

Receive News & Ratings for Healthways Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthways Inc. and related companies with MarketBeat.com's FREE daily email newsletter.